CSIMarket
 
Prestige Consumer Healthcare Inc   (PBH)
Other Ticker:  
 
 
Price: $68.2800 $0.18 0.264%
Day's High: $68.5 Week Perf: -0.06 %
Day's Low: $ 67.61 30 Day Perf: -5.31 %
Volume (M): 201 52 Wk High: $ 75.80
Volume (M$): $ 13,690 52 Wk Avg: $66.49
Open: $68.00 52 Wk Low: $56.61



 Market Capitalization (Millions $) 3,432
 Shares Outstanding (Millions) 50
 Employees 570
 Revenues (TTM) (Millions $) 1,113
 Net Income (TTM) (Millions $) 471
 Cash Flow (TTM) (Millions $) -20
 Capital Exp. (TTM) (Millions $) 9

Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc. is a leading provider of over-the-counter healthcare and wellness solutions in the United States and internationally. Headquartered in Tarrytown, New York, Prestige Consumer Healthcare operates through three business segments: North American Over-the-Counter (OTC) Healthcare, International OTC Healthcare, and Household Cleaning. The company has a longstanding history of providing effective and high-quality products and has developed a strong reputation for offering trustworthy brands that consumers can rely on.

The North American Over-the-Counter Healthcare segment offers a range of products to customers in the US and Canada, including oral analgesics, cough and cold remedies, allergy treatments, and gastrointestinal products. Some of the company's most recognized brands fall under this category, such as BC Headache Powder, Fleet enema, and Goody's headache powder. The International OTC Healthcare segment, on the other hand, offers well-known brands such as Clear Eyes, Gaviscon, and BC powder across Europe, Australia, and Canada.

The Household Cleaning segment includes the Comet, Spic and Span, and Chore Boy brands, which offer a range of cleaning solutions, such as bathroom cleaners, dishwashing detergents, and sponges. These brands are found in many US households and have earned a reputation for providing exceptional cleaning performance.

The company's success is a result of its commitment to the highest standards of quality, innovation, and customer satisfaction. It invests heavily in research and development and has established a reputation for consistently developing new and innovative products that meet the changing needs of its customers. Its commitment to quality is evident in every product it produces with a strong focus on safety, efficacy, and environmental sustainability.

Prestige Consumer Healthcare is a publicly-traded company, listed on the New York Stock Exchange under the ticker symbol ePBH.e It has a diverse and experienced management team, led by CEO Ron Lombardi, overseeing operations across the globe. The company has grown significantly over the years, through a combination of organic growth and strategic acquisitions, to become one of the leading providers of OTC healthcare and wellness solutions in the world today.


   Company Address: 660 White Plains Road Tarrytown 10591 NY
   Company Phone Number: 524-6800   Stock Exchange / Ticker: NYSE PBH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc. Reports Strong Financial Performance Despite Decline in Sales

Prestige Consumer Healthcare Inc. (PBH) has shown strong financial performance in the fourth quarter of 2024, turning a profit despite a decline in sales. The company reported earnings per share of $0.98, an improvement from the previous year's net loss of $-446.159 million. Revenue decreased by -2.817% to $277.82 million, but the company was able to increase its profit margins, with a net margin of 42.03% and an operating margin of 29.57%.
For the full fiscal year 2024, Prestige Consumer Healthcare Inc. recorded earnings of $485.36 million and revenue of $1.12 billion. Earnings per share increased to $4.17 from a loss of $-1.65 in the previous financial year. Despite a slight decrease in revenue (-0.29%), the company's profitability has improved significantly.

Product Service News

Dramamine turns 75, Gives a Chic Makeover to Barf Bags in a Trend-setting Anniversary Celebration

Published Wed, Apr 3 2024 3:57 PM UTC

In a unique and engaging way to celebrate its 75th anniversary, the renowned nausea-fighting brand, Dramamine, is partnering with an unexpected ally: the barf bag. The iconic brand is known for coming to the rescue of stomachs everywhere and now plans to pay homage to its lower-profile accomplice in the fight against nausea.For the uninitiated, morning sickness, sea sickness...

Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc Beats the Odds with 2.328% Revenue Growth in Challenging Market Environment

The stock market can be a volatile and unpredictable environment, with companies facing a myriad of challenges that can impact their financial performance. Prestige Consumer Healthcare Inc, a major player in the pharmaceutical industry, recently announced its financial results for the third quarter of 2024. While the company saw a moderate revenue improvement of 2.328% to $281.94 million, income only grew by 1.92% year on year.
One interesting fact to note is that Prestige Consumer Healthcare Inc experienced a decrease in revenue by -1.427% from the previous quarter. This could be a cause for concern for investors, as it may indicate a slowdown in sales or market demand for the company's products. Additionally, the net profit per share decreased by -0.93% from the previous year, further highlighting the challenges the company may be facing in terms of profitability.

Product Service News

'Insight Pharmaceuticals Announces Precautionary Nationwide Recall of Select Athlete's Foot Spray Lots Over Benzene Concerns'

Published Fri, Feb 2 2024 2:00 PM UTC

Tarrytown-based pharmaceutical company, Insight Pharmaceuticals, a subsidiary of Prestige Consumer Healthcare Inc., has announced a voluntary nationwide recall of two lots of its TING 1% Tolnaftate Athletes Foot Spray Antifungal Spray Liquid due to the presence of benzene. In a press release dated Feb. 02, 2024, the company mentioned the issue was unearthed during a recent ...

Product Service News

Insight Pharmaceuticals Recalls TING 2% Miconazole Nitrate Athletes Foot Spray Due to Elevated Levels of Benzene

Published Fri, Nov 24 2023 1:30 PM UTC


Introduction
Insight Pharmaceuticals, a subsidiary of Prestige Consumer Healthcare Inc., has issued a voluntary recall of two lots of TING 2% Miconazole Nitrate Athletes Foot Spray Antifungal Spray Powder, due to the presence of elevated levels of benzene. Although benzene is not an ingredient in any Ting Antifungal Spray products, the review revealed that unexpecte...







Prestige Consumer Healthcare Inc's Segments
North American OTC Healthcare    86.96 % of total Revenue
International OTC Healthcare    13.04 % of total Revenue
Intersegment Eliminations North American OTC Healthcare    0.26 % of total Revenue
Analgesics    10.59 % of total Revenue
Cough & Cold    7.75 % of total Revenue
InterEliminations North American OTC Healthcare    0.26 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com